Dr. Wilken received his undergraduate degree from Cornell University and his master’s and doctoral degrees in clinical psychology from the University of Maryland at College Park. He completed his post-doctoral fellowship in clinical neuropsychology at Georgetown University Medical Center and the Veteran Affairs Medical Center in Washington, D.C. He also received training in neuropsychology at the NIH (NINDS), Johns Hopkins Medical Center, and Walter Reed Army Medical Center. He is an Assistant Professor of Neurology at Georgetown University Medical Center, a partner at the Neuropsychology Associates of Fairfax (NAF), and the Executive Director of the Washington Neuropsychology Research Group (WNRG).

For over 25 years, he has dedicated his career to research and clinical care in MS. With respect to his research, he has examined the impact of disease modifying agents and adjunctive medications on cognitive functioning in people with MS. He also has worked to validate computerized testing and screening batteries for use in the neurologist’s office. He presents his MS research at scientific conferences worldwide, he has authored and co-authored many publications in peer-reviewed scientific journals, and he has given lectures on MS to physicians and MS patients (both domestically and internationally). In his clinical practice, he also specializes in the neuropsychological assessment of MS patients. He works closely with many of the MS specialty clinics/programs in the Washington, D.C. area (including the MS center at Georgetown University and the INOVA hospital system).

Dr. Wilken has been on the Board of Governors for the Consortium of Multiple Sclerosis Centers (CMSC) as a co-chair of the Mental Health Special Interest Group (2016 to 2020) and a member at large, and he recently was on a CMSC advisory board that addressed cognitive functioning in people with MS. For 20 years, he has served as a judge and moderator for abstracts, posters, and platforms presented at the CMSC annual meetings, and he currently is President-Elect of the CMSC (with his Presidential term to occur in 2024 and 2025). Finally, he is a past member of the Clinical Advisory Committee for the National Multiple Sclerosis Society (NMSS).